C3‐Tat/HIV–regulated intraarticular human interleukin‐1 receptor antagonist gene therapy results in efficient inhibition of collagen‐induced arthritis superior to cytomegalovirus‐regulated expression of the same transgene

Abstract

Our data demonstrate for the first time the feasibility of an inducible expression system for local production of IL-1Ra for treatment of arthritis in the CIA model.